Theralase Technologies Inc. V.TLT

Theralase AUA Pesentation at annual meeting

[Watchfuleye27]

If the Theralase presentation over the weekend was well received at the AUA annual meeting the stock will do well over the medium to long time frame. Posters that are nitpicking the numbers may have fun but these posts are not very relevant to the overall process. Theralase will either get FDA approval soon or big pharma will push to buy Theralase within the next 1 to 2 years. I personally love the science but have been very disappointed by the lack of progess over many years. This science needs to be released to help the many patients in need.

[Legit62]

Doesnt look as though we were well received at AUA with this stock price drop off

[chry200030]

Not with this volume. 

[Gooseybear]

If they presented the same material in the same format as they did in their financials, no wonder not well received.

[99942Apophis]

Hi Legit62,  I will strongly repeat the remarks I made about the clinicians meeting which also applies to this AUA presentation and that is there are very few people that attend these meetings that are retail stock buyers.  If anything they invest into is done through their financial advisors and probably mutual funds or hedge funds. A person attending in todays medical environment is

[Gooseybear]

Once someone at the FDA gets bladder cancer and goes through 20 BCG treatments like I have, they will get off their butts and appreciate Theralase.